-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 30/05/25 )
NAV
₹38.54
Last change
₹-0.21 -0.01%
Fund Size (AUM)
5295.32 Cr
Performance
25.6% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 30/05/25
AUM
5295.32 Cr
Expense Ratio
1.91 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 25.05% | 27.74% | 25.6% |
| BSE Healthcare TR INR | 22.11% | 23.78% | 22.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.23% |
Dr Reddy's Laboratories Ltd |
9.5% |
Cipla Ltd |
8.63% |
Divi's Laboratories Ltd |
7.81% |
Aurobindo Pharma Ltd |
7.05% |
Lupin Ltd |
4.43% |
Alkem Laboratories Ltd |
4.3% |
Zydus Lifesciences Ltd |
3.89% |
Gland Pharma Ltd |
3.62% |
Syngene International Ltd |
2.2% |
Sector Allocation
Healthcare |
93.71% |
Basic Materials |
4.74% |
Financial |
1.55% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
25.6% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.82% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.14% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.14% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
21.83% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
21.83% (5Y)
-
